These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188 [TBL] [Abstract][Full Text] [Related]
26. Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin. Fisher RW; Reed JL; Snoy PJ; Mikolajczyk MG; Bray M; Scott DE; Kennedy MC Clin Vaccine Immunol; 2011 Jan; 18(1):67-74. PubMed ID: 21106779 [TBL] [Abstract][Full Text] [Related]
27. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. Reading PC; Symons JA; Smith GL J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits. Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Quenelle DC; Keith KA; Kern ER Antiviral Res; 2006 Aug; 71(1):24-30. PubMed ID: 16621041 [TBL] [Abstract][Full Text] [Related]
30. Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201). Smee DF; Wong MH; Russell A; Ennis J; Turner JD PLoS One; 2011; 6(10):e26330. PubMed ID: 22022603 [TBL] [Abstract][Full Text] [Related]
31. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice. Quenelle DC; Collins DJ; Herrod BP; Keith KA; Trahan J; Beadle JR; Hostetler KY; Kern ER Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137 [TBL] [Abstract][Full Text] [Related]
32. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564 [TBL] [Abstract][Full Text] [Related]
33. A recombinant vaccinia virus encoding inducible nitric oxide synthase is attenuated in vivo. Rolph MS; Cowden WB; Medveczky CJ; Ramshaw IA J Virol; 1996 Nov; 70(11):7678-85. PubMed ID: 8892888 [TBL] [Abstract][Full Text] [Related]
34. Measurements of vaccinia virus dissemination using whole body imaging: approaches for predicting of lethality in challenge models and testing of vaccines and antiviral treatments. Zaitseva M; Kapnick S; Golding H Methods Mol Biol; 2012; 890():161-76. PubMed ID: 22688767 [TBL] [Abstract][Full Text] [Related]
35. [5-iodo-2'-deoxyuridine (IDU) in the treatment of ocular infection caused by vaccinia virus]. Vitiello L Ann Ottalmol Clin Ocul; 1967 May; 93(5):519-25. PubMed ID: 5604221 [No Abstract] [Full Text] [Related]
36. Vaccinia virus replication is independent of cellular HSP72 expression which is induced during virus infection. Sedger L; Ramshaw I; Condie A; Medveczky J; Braithwaite A; Ruby J Virology; 1996 Nov; 225(2):423-7. PubMed ID: 8918931 [TBL] [Abstract][Full Text] [Related]
37. Ceragenins: a class of antiviral compounds to treat orthopox infections. Howell MD; Streib JE; Kim BE; Lesley LJ; Dunlap AP; Geng D; Feng Y; Savage PB; Leung DY J Invest Dermatol; 2009 Nov; 129(11):2668-75. PubMed ID: 19516269 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless mice. Tarbet EB; Larson D; Anderson BJ; Bailey KW; Wong MH; Smee DF Antiviral Res; 2011 Jun; 90(3):126-33. PubMed ID: 21439326 [TBL] [Abstract][Full Text] [Related]
39. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375 [TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of the EB peptide against zoonotic poxviruses. Altmann SE; Brandt CR; Jahrling PB; Blaney JE Virol J; 2012 Jan; 9():6. PubMed ID: 22225618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]